• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

经颈静脉肝内门体分流术治疗有症状的肝硬化性胸腔积液

Transjugular intrahepatic portal systemic shunt for the management of symptomatic cirrhotic hydrothorax.

作者信息

Strauss R M, Martin L G, Kaufman S L, Boyer T D

机构信息

Department of Medicine, Emory University School of Medicine, Atlanta, Georgia.

出版信息

Am J Gastroenterol. 1994 Sep;89(9):1520-2.

PMID:8079930
Abstract

OBJECTIVE

To investigate the safety and effectiveness of performing transjugular intrahepatic portal systemic shunt (TIPS) for the management of symptomatic cirrhotic hydrothorax in patients with advanced cirrhosis.

METHODS

TIPS was performed by standard technique after portal vein patency had been established by ultrasound. Portal-hepatic vein pressure gradient was determined before and after placement of the shunt. A portal-hepatic vein gradient of less than 12 mm Hg was the treatment goal.

RESULTS

Five patients underwent TIPS placement over an 11-month period. Despite use of diuretics, the patients had required a median of seven thoracenteses (range 2-11) for control of symptoms preceding placement of the shunt. A TIPS was placed without serious complications in all five patients. In two patients, insertion of the shunt was associated with no further need for thoracentesis. The other three patients had recurrent need for thoracentesis. These three patients were found to have occluded shunts which were rendered patent by angioplasty and/or urokinase. Subsequently, two required no further thoracentesis, whereas, in the other patient, the need for thoracentesis was decreased dramatically.

CONCLUSIONS

TIPS appears to be a safe and useful technique for the management of patients with symptomatic cirrhotic hydrothorax that is refractory to medical therapy. Recurrence of the pleural effusion after placement of TIPS may be an indication of shunt occlusion.

摘要

目的

探讨经颈静脉肝内门体分流术(TIPS)治疗晚期肝硬化患者症状性肝硬化胸腔积液的安全性和有效性。

方法

在超声确定门静脉通畅后,采用标准技术进行TIPS。在放置分流器前后测定门静脉-肝静脉压力梯度。门静脉-肝静脉梯度小于12 mmHg为治疗目标。

结果

在11个月期间,5例患者接受了TIPS放置。尽管使用了利尿剂,但患者在放置分流器前为控制症状平均需要进行7次胸腔穿刺(范围2-11次)。所有5例患者放置TIPS均无严重并发症。2例患者放置分流器后无需进一步胸腔穿刺。其他3例患者反复需要胸腔穿刺。发现这3例患者的分流器堵塞,通过血管成形术和/或尿激酶使其通畅。随后,2例患者无需进一步胸腔穿刺,而另1例患者胸腔穿刺的需求显著减少。

结论

TIPS似乎是治疗药物治疗无效的症状性肝硬化胸腔积液患者的一种安全有效的技术。TIPS放置后胸腔积液复发可能提示分流器堵塞。

相似文献

1
Transjugular intrahepatic portal systemic shunt for the management of symptomatic cirrhotic hydrothorax.经颈静脉肝内门体分流术治疗有症状的肝硬化性胸腔积液
Am J Gastroenterol. 1994 Sep;89(9):1520-2.
2
The successful treatment of symptomatic, refractory hepatic hydrothorax with transjugular intrahepatic portosystemic shunt.经颈静脉肝内门体分流术成功治疗有症状的难治性肝性胸腔积液。
Hepatology. 1997 Jun;25(6):1366-9. doi: 10.1002/hep.510250611.
3
Outcome of 100 patients after transjugular intrahepatic portosystemic shunt for variceal hemorrhage.100例患者经颈静脉肝内门体分流术治疗静脉曲张出血后的结局
Am J Gastroenterol. 1997 Sep;92(9):1444-52.
4
[Hepatic hydrothorax].[肝性胸水]
Z Gastroenterol. 2005 Dec;43(12):1319-28. doi: 10.1055/s-2005-858742.
5
[Hydrothorax in absence of ascites: an unusual complication of hepatic cirrhosis with portal hypertension].[无腹水的胸腔积液:肝硬化门静脉高压的一种罕见并发症]
Clin Ter. 2005 Jul-Aug;156(4):179-81.
6
Transjugular intrahepatic portosystemic shunt placement in patients with cirrhosis and concomitant portal vein thrombosis.肝硬化合并门静脉血栓形成患者的经颈静脉肝内门体分流术置入
Cardiovasc Intervent Radiol. 2006 Sep-Oct;29(5):785-90. doi: 10.1007/s00270-005-0090-4.
7
Cirrhotic patients with a transjugular intrahepatic portosystemic shunt undergoing major extrahepatic surgery.接受大型肝外手术的经颈静脉肝内门体分流术肝硬化患者。
J Clin Gastroenterol. 2009 Jul;43(6):574-9. doi: 10.1097/MCG.0b013e31818738ef.
8
Hepatic hydrothorax.肝性胸水
Semin Liver Dis. 1997;17(3):227-32. doi: 10.1055/s-2007-1007200.
9
Type-2 hepatorenal syndrome and refractory ascites: role of transjugular intrahepatic portosystemic stent-shunt in eighteen patients with advanced cirrhosis awaiting orthotopic liver transplantation.2型肝肾综合征与顽固性腹水:经颈静脉肝内门体分流术在18例等待原位肝移植的晚期肝硬化患者中的作用
Hepatogastroenterology. 2003 Nov-Dec;50(54):1753-5.
10
Transjugular intrahepatic portosystemic shunts and liver transplantation in patients with refractory hepatic hydrothorax.经颈静脉肝内门体分流术与难治性肝性胸腔积液患者的肝移植
Liver Transpl Surg. 1998 Sep;4(5):416-23. doi: 10.1002/lt.500040506.

引用本文的文献

1
Outcome of Transjugular Intrahepatic Portosystemic Shunt in Patients with Cirrhosis and Refractory Hepatic Hydrothorax: A Systematic Review and Meta-analysis.经颈静脉肝内门体分流术治疗肝硬化合并难治性肝性胸腔积液患者的疗效:一项系统评价和Meta分析
Indian J Radiol Imaging. 2024 May 18;34(4):670-676. doi: 10.1055/s-0044-1786828. eCollection 2024 Oct.
2
Medical thoracoscopy with talc pleurodesis for refractory hepatic hydrothorax: A case series of three successes.滑石粉胸膜固定术的医学胸腔镜检查治疗难治性肝性胸水:三例成功病例系列
Respir Med Case Rep. 2024 May 16;50:102039. doi: 10.1016/j.rmcr.2024.102039. eCollection 2024.
3
International survey among hepatologists and pulmonologists on the hepatic hydrothorax: plea for recommendations.
国际肝病学家和肺科医生对肝性胸水的调查:呼吁制定建议。
BMC Gastroenterol. 2023 Sep 12;23(1):305. doi: 10.1186/s12876-023-02931-z.
4
Natural history and outcomes of patients with liver cirrhosis complicated by hepatic hydrothorax.肝硬化合并肝性胸水患者的自然史和结局。
World J Gastroenterol. 2022 Sep 21;28(35):5175-5187. doi: 10.3748/wjg.v28.i35.5175.
5
Efficacy and Safety of Indwelling Pleural Catheters in Management of Hepatic Hydrothorax: A Systematic Review of Literature.留置胸膜导管治疗肝性胸水的疗效与安全性:文献系统评价
Cureus. 2018 Aug 6;10(8):e3110. doi: 10.7759/cureus.3110.
6
Diffrential Diagnosis of Hepatic Hydrothorax by Tc Sulfur Colloid Peritoneal Scintigraphy: Two Cases.锝硫胶体腹膜闪烁显像对肝性胸水的鉴别诊断:两例报告
Gastroenterology Res. 2009 Aug;2(4):248-252. doi: 10.4021/gr2009.08.1310. Epub 2009 Jul 20.
7
Effect of technical parameters on transjugular intrahepatic portosystemic shunts utilizing stent grafts.技术参数对使用覆膜支架的经颈静脉肝内门体分流术的影响。
World J Gastroenterol. 2015 Jul 14;21(26):8110-7. doi: 10.3748/wjg.v21.i26.8110.
8
Transjugular intrahepatic portosystemic stent shunt for medically refractory hepatic hydrothorax: A systematic review and cumulative meta-analysis.经颈静脉肝内门体分流术治疗内科难治性肝性胸水:一项系统评价和累积荟萃分析
World J Hepatol. 2015 Jul 8;7(13):1797-806. doi: 10.4254/wjh.v7.i13.1797.
9
Transjugular intrahepatic portosystemic shunts and portal hypertension-related complications.经颈静脉肝内门体分流术与门静脉高压相关并发症
World J Gastroenterol. 2014 Dec 7;20(45):16996-7010. doi: 10.3748/wjg.v20.i45.16996.
10
Selection of a TIPS stent for management of portal hypertension in liver cirrhosis: an evidence-based review.用于肝硬化门静脉高压症治疗的经颈静脉肝内门体分流术(TIPS)支架的选择:一项循证综述
World J Gastroenterol. 2014 Jun 7;20(21):6470-80. doi: 10.3748/wjg.v20.i21.6470.